01
Early Drug Discovery Projects
Assay development, target validation, hit characterization, and lead optimization across biochemical and cell-based formats for early-stage discovery programs.
03 / Services
Contract Research Support
When you need experimental capacity without growing headcount, we plan and execute studies end-to-end. Discovery-stage biology, hepatotoxicity work, rodent in-vivo studies, CRO oversight, and the scientific writing that closes them out.
What we offer
02
Hepato-toxicity Studies (Cells / Organoids)
Drug-induced liver injury (DILI) screening in primary human hepatocytes, HepG2, HepaRG, and 3D liver organoid models, with endpoints spanning viability, mitochondrial function, and CYP modulation.
03
Rodent In-Vivo Studies
Study design, IACUC support, and execution of PK, PD, efficacy, and tolerability studies in rodent models, including multiple routes of administration, scheduled sampling, tissue collection, and histopathology coordination.
04
CRO Management
RFP development, vendor selection, contract negotiation, milestone tracking, and data quality review for external CROs, so your team stays focused on science.
05
Scientific Writing
Peer-reviewed manuscripts, SBIR / STTR and NIH grant submissions, FDA regulatory documents, study reports, and technical writing prepared by experienced scientific writers.
Have a project in mind?
Tell us about your lab and we will scope the right level of support together.